IXHL
Incannex Healthcare Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$3.25
−0.15%Margins
Gross margin
-192.7%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-66.4%
Return on equity
-62.2%
Return on assets
-46.2%
Return on invested capital
0.00x
Asset turnover
-$12.5M
Cash from operations
$6.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026